Genentech (RHHBY) Receives FDA Breakthrough Therapy Designation for ACE910
Tweet Send to a Friend
Genentech, a member of the Roche Group (OTCBB: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has granted ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE